Abstract
Background. The chronic myeloproliferative diseases (CMPDs) include chronic myelogenous leukemia (CML), primary (essential) thrombocythemia (PT), agnogenic myeloid metaplasia (AMM), and polycythemia vera (PV). Certain hematological malignancies have a different prevalence in our country than in countries with Caucasian populations. Data indicate that the prevalence of CML in our country is similar to that found in Caucasians; however, the prevalence of the other CMPDs has not been studied.
Methods. In a total of 8069 individuals studied between June 1983 and March 2001 in the Centro de Hematologia y Medicina Interna de Puebla, we assessed the prevalence of CML, PT, AMM, and PV. Some of the clinical features of these individuals were also assessed.
Results and Conclusions. Forty-nine patients with CML, 14 with PT, 7 with AMM, and 3 with PV were identified. The clinical presentations of these CMPDs were not different from those described in Caucasians.
Conclusions.We found that CML was more than 3 times more frequent than PT, that both PV and AMM were exceptional, and that PT, AMM, and PV were significantly less frequent in Mexican than in Caucasian populations (P < .01).Int J Hematol. 2002;75:499–502.
Similar content being viewed by others
References
Tefferi A. Chronic myeloid disorders: classification and treatment overview.Semin Hematol. 2001;38(suppl 2):1–4.
Messinezy M, Pearson TC. Polycythaemia, primary (essential) thrombocythaemia and myelofibrosis.Br Med J. 1997;314:587–590.
Labardini-Méndez J. Chronic myeloproliferative disorders. In: Ruiz-Argüelles GJ, ed.Fundamentos de Hematologia.2nd ed. México City: Editorial Médica Panamericana; 1998:209–222.
Murphy S. Diagnostic criteriae and prognosis in polycythemia vera and essential thrombocythemia.Semin Hematol. 1999; 36(suppl 2):9–15.
Messinezy M, Westwood N, Sawyer B, et al. Primary thrombo-cythaemia: a composite approach to diagnosis.Clin Lab Haematol. 1994;16:139–148.
Arends T, Arends A. Introducción a la hematología geográfica. In: López-Borrasca A, Arocha-Piñango CL, Campos-Guerra C, et al, eds.Enciclopedia Iberoamericana de Hematología. Salamanca, Spain: Ediciones Universidad de Salamanca. 1992;IV:601–602.
Lisker R, Ramírez E, Pérez-Briceño R, Granados J, Babinsky V. Gene frequencies and admixture estimates in four Mexican urban centers.Hum Biol. 1990;62:791–794.
Ruiz-Argüelles GJ. Promyelocytic leukaemia in Mexican mestizos.Blood. 1997;89:348–349.
Ruiz-Argüelles GJ, Lobato-Mendizábal E, San-Miguel JF, et al. Long-term treatment results for megakaryoblastic leukaemia patients: a multicentre study.Br J Haematol. 1992;82:671–675.
Lobato-Mendizábal E, Ruiz-Argüelles GJ. Prevalencia y características de la leucemia linfoblástica de células pre-B en México.Sangre. 1991;36:1–5.
Ruiz-Argüelles GJ, Cantú-Rodríguez OG, Gómez-Almaguer D, et al. Hairy cell leukemia is infrequent in México and has a geographic distribution.Am J Hematol. 1996;52:316–318.
Alemán-Hoey DD, Ruiz-Argüelles GJ, Verduzco-Rodriguez L, López-Ariza B, Labardini JR. Leucemia linfocítica crónica, I: experiencia de 35 años en el Instituto Nacional de la Nutrición Salvador Zubirán.Rev Invest Clín Méx. 1982;34:151–156.
Ruiz-Argüelles GJ, Velázquez BM, Apreza-Molina MG, Pérez-Romano B, Ruiz-Reyes G, Ruiz-Argüelles A. Chronic lymphocytic leukemia is infrequent in Mexican Mestizos.Int J Hematol.1999;69: 253–255.
Ruiz-Argüelles GJ, Cantú-Rodriguez OG, Mercado-Díaz L, et al. Some chronic lymphoproliferative malignancies in México are less frequent than in Caucasian populations.Blood. 1996; 88(suppl 1):217b.
Ruiz-Argüelles GJ, Ramírez-Cisneros FJ, Flores-Martínez J, Cernuda-Graham MC. Waldenström’s macroglobulinemia is infrequent in Mexican Mestizos: experience of a hematological diseases referral center.Rev Invest Clín Méx. 2000;52:497–499.
Ruiz-Argüelles GJ, López-Martínez B, Ramírez-Cabrera JM, Reyes-Nuñez V, Rodríguez-Cedeño H, Garcés-Eisele J. Molecular monitoring of the treatment of patients with BCR/ABL (+) chronic myelogenous leukemia.Rev Invest Clín Méx. 2001;53: 235–239.
Velázquez-Hernández BM, Ruiz-Argüelles GJ, Apreza-Molina MG. Resultados a largo plazo del tratamiento de pacientes con leucemia granulocítica crónica con busulfán y/o hidroxiurea. Estudio prospectivo.Med Int Méx. 1996;12:97.
Mesa RA, Silverstein MV, Jacobsen SJ, Wollan PC, Tefferi A. Population-based incidence and survival figures in essential thrombo-cythemia and agnogenic myeloid metaplasia: an Olmsted County study, 1976–1995.Am J Hematol. 1999;61:10–15.
Kantarjian HM, Talpaz M, Gutterman JU. Chronic myelogenous leukemia: past, present and future.Hematol Pathol. 1988;2:91–120.
Ruiz-Argüelles GJ, Garcés-Eisele J, Reyes-Núñez V, et al. Assessment of residual disease in acute leukemia by means of polymerase chain reaction: a prospective study in a single institution.Rev Invest Clin Mex. 2000;52:118–124.
Ruiz-Argüelles GJ, Ruiz-Delgado GJ, Ruiz-Reyes G, Chernoff SG. Anagrelide-induced relapse of a hydroxyurea-induced leg ulcer in a patient with primary thrombocythemia.Mayo Clin Proc. 1998; 73:1125.
Ruiz-Argüelles GJ, Lobato-Mendizábal E, Ruiz-Argüelles A, Pérez-Romano B, Arizpe-Bravo D, Marín-López A. Non-cryopre-served unmanipulated hematopoietic peripheral blood stem cell autotransplant program: long-term results.Arch Med Res. 1999;30: 380–384.
Silverstein MN, Tefferi A. Treatment of essential thrombocythemia with anagrelide.Semin Hematol. 1999;36:23–25.
Tefferi A, Silverstein MN, Hoagland HC. Primary thrombo-cythemia.Semin Oncol. 1995;22:334–340.
Ruiz-Argüelles GJ, Marín-López A, Lobato-Mendizábal E, Gamboa-Ojeda I, Sánchez-Anzaldo FJ. El cromosoma Philadelphia lesiona la célula totipotencial: trombocitosis primaria t (9q+; 22q-).Rev Invest Clin Méx. 1984;36:49–51.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Ruiz-Argüelles, G.J., López-Martínez, B., Lobato-Mendizábal, E. et al. An Addition to Geographic Hematology: Chronic Myeloproliferative Diseases Are Infrequent in Mexican Mestizos. Int J Hematol 75, 499–502 (2002). https://doi.org/10.1007/BF02982113
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02982113